Results 261 to 270 of about 86,778 (305)

N-terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome.

J Clin Endocrinol Metab
Nicoli CD, Long DL, Plante TB, Judd SE, McClure LA, Carson AP, Cushman M.   +6 more
europepmc   +1 more source

Comparison of the Cardiac Markers B-type Natriuretic Peptide and N-terminal Pro B-type Natriuretic Peptide

Biomarkers in Medicine, 2009
B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide have emerged as powerful biomarkers for heart failure and other cardiovascular conditions. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are synthesized on the basis of myocardial stress and hypertrophy and are detectable in serum by several commercially
Stefan, Buchner, Carsten, Jungbauer, Christoph, Birner, Kurt, Debl, Günter A, Riegger, Andreas, Luchner   +5 more
openaire   +3 more sources

C-Type Natriuretic Peptide

Peptides, 1996
C-type natriuretic peptide is a 22-amino acid peptide that was initially identified in the central nervous system. The distribution of C-type natriuretic peptide, which has structural homology with atrial and brain natriuretic peptides, is wide and ...
Allan D Struthers
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

B-type Natriuretic Peptides in Heart Failure

Biomarkers in Medicine, 2007
There is increasing interest in the B-type natriuretic peptides in many clinical settings, with most research centered on patients with heart failure. These peptides have a strong negative predictive value in patients suspected of having this diagnosis, but are also known to be powerfully predictive of an adverse outcome.
Roy S, Gardner, Kwok S, Chong, Theresa A, McDonagh   +2 more
openaire   +2 more sources

B-Type Natriuretic Peptide and Renal Disease

Heart Failure Reviews, 2003
B-type natriuretic peptide (BNP) is a cardiac neurohormone which has a principal effect on the kidney to signal both natriuresis and diuresis. Both BNP and renal function are prognostic indicators of survival in patients with congestive heart failure (CHF).
Peter A, McCullough, Keisha R, Sandberg
openaire   +2 more sources

B-Type Natriuretic Peptide for Diagnosis and Therapy

Recent Patents on Cardiovascular Drug Discovery, 2008
Brain natriuretic peptide (BNP) plays an important role in cardiovascular homeostasis. Plasma BNP increases markedly in left ventricular dysfunction from several causes, and its levels in heart failure (HF) correlate with symptoms severity. BNP has recently emerged as a potentially important clinical marker for the diagnosis of HF in patients with ...
openaire   +2 more sources

B-type natriuretic peptide in heart failure

Current Opinion in Cardiology, 2006
This review focuses on recent literature pertaining to the role of B-type natriuretic peptide (BNP) in heart failure.Heart failure is a common disorder that is associated with significant mortality and morbidity. The diagnosis of heart failure may at times be difficult when using conventional tools.
openaire   +2 more sources

B-Type Natriuretic Peptide

2003
In 1988, Sudoh and co-workers first isolated a novel peptide from porcine brain and designated the peptide “brain natriuretic peptide,” or BNP, based on its similarity to atrial natriuretic peptide (ANP) (1). BNP also was isolated from the cardiac tissue of pigs, rats, and humans (2–5).
openaire   +1 more source

B-type natriuretic peptide in the cardiology department.

Irish medical journal, 2012
Heart Failure is one of the fastest growing cardiovascular diseases of the 21st century. Echocardiogram is considered the gold standard for diagnosis, but is costly, time consuming and not readily accessible to all patients. Our aim was to assess the diagnostic utility of BNP to risk stratify patients for ECHO.
Shea, P, Daly, R, Kasim, S, Tormey, WP
openaire   +2 more sources

B-Type Natriuretic Peptide — A Window to the Heart

New England Journal of Medicine, 2002
Left ventricular dysfunction, regardless of its cause, results in characteristic hemodynamic derangements and a process of neurohormonal activation.
openaire   +2 more sources